PROCTER & GAMBLE HEALTH LIMITEPROCTER & GAMBLE HEALTH LIMITEPROCTER & GAMBLE HEALTH LIMITE

PROCTER & GAMBLE HEALTH LIMITE

No trades
See on Supercharts
Market capitalization
‪77.90 B‬INR
‪2.29 B‬INR
‪12.29 B‬INR
‪7.94 M‬
Beta (1Y)
0.02

About PROCTER & GAMBLE HEALTH LIMITE

CEO
Milind Thatte
Headquarters
Mumbai
Employees (FY)
‪1.6 K‬
Founded
1967
ISIN
INE199A01012
FIGI
BBG000CQR0Z0
Procter & Gamble Health Ltd. engages in the manufacture and marketing of pharmaceuticals products. It offers its products through the following brands: Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. It operates through India, and Outside India geographical segments. The company was founded in 1967 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PGHL is 4697.50 INR — it has increased by 0.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange PROCTER & GAMBLE HEALTH LIMITE stocks are traded under the ticker PGHL.
PROCTER & GAMBLE HEALTH LIMITE is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
PGHL stock is 1.36% volatile and has beta coefficient of 0.02. Check out the list of the most volatile stocks — is PROCTER & GAMBLE HEALTH LIMITE there?
Yes, you can track PROCTER & GAMBLE HEALTH LIMITE financials in yearly and quarterly reports right on TradingView.
PGHL stock has fallen by 2.51% compared to the previous week, the month change is a 3.02% fall, over the last year PROCTER & GAMBLE HEALTH LIMITE has showed a 0.27% decrease.
PGHL net income for the last quarter is ‪720.70 M‬ INR, while the quarter before that showed ‪655.70 M‬ INR of net income which accounts for 9.91% change. Track more PROCTER & GAMBLE HEALTH LIMITE financial stats to get the full picture.
Today PROCTER & GAMBLE HEALTH LIMITE has the market capitalization of ‪77.90 B‬, it has increased by 0.29% over the last week.
PROCTER & GAMBLE HEALTH LIMITE dividend yield was 1.81% in 2023, and payout ratio reached 68.72%. The year before the numbers were 1.25% and 45.27% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, PGHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROCTER & GAMBLE HEALTH LIMITE stock right from TradingView charts — choose your broker and connect to your account.
PGHL reached its all-time high on Feb 11, 2021 with the price of 7499.95 INR, and its all-time low was 260.00 INR and was reached on Oct 27, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.60 K‬ employees. See our rating of the largest employees — is PROCTER & GAMBLE HEALTH LIMITE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROCTER & GAMBLE HEALTH LIMITE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROCTER & GAMBLE HEALTH LIMITE stock shows the neutral signal. See more of PROCTER & GAMBLE HEALTH LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROCTER & GAMBLE HEALTH LIMITE EBITDA is ‪3.15 B‬ INR, and current EBITDA margin is 26.77%. See more stats in PROCTER & GAMBLE HEALTH LIMITE financial statements.